# iShares Biotechnology ETF (IBB) — Overview

IBB · NASDAQ · Fund

Canonical page: https://www.lighthorse.io/tickers/ibb

## Price

Last close $207.41 on Oct 15, 2026. 52-week range $151.32 – $216.96.

## Fund profile

IBB tracks the performance of a modified market-cap-weighted index of US biotechnology companies listed on US exchanges.

| Metric | Value |
| --- | --- |
| Issuer | BlackRock Fund Advisors |
| Industry | Healthcare |
| Inception | Feb 5, 2001 |
| Assets under management | $10.5B |
| Expense ratio | 0.44% |
| Net asset value | $203.22 (as of Oct 14, 2026) |
| Distributions | Quarterly |
| Leverage | 1x |

## Frequently Asked Questions

### What is iShares Biotechnology ETF (IBB)?

IBB tracks the performance of a modified market-cap-weighted index of US biotechnology companies listed on US exchanges.

### What is IBB's expense ratio?

iShares Biotechnology ETF charges an annual expense ratio of 0.44%. The fund is issued by BlackRock Fund Advisors.

### How large is IBB?

iShares Biotechnology ETF manages $10.5B in assets and has traded since Feb 5, 2001.

### How do I buy shares of iShares Biotechnology ETF (IBB)?

IBB trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).